TLR9 and cutaneous lupus erythematosus: Hydrochloroquine also reduces type I IFN production of TLR7 or TLR9 activated pDCs in patients with SLE [195] and also inhibits TLR9 activation-induced type I IFN production by pDCs of cutaneous lupus erythematosus patients [196].